The number of patients undergoing transcatheter aortic valve replacement (TAVR) worldwide is increasing steadily. Atrioventricular conduction disturbances, with or without the need for permanent pacemaker (PPM) implantation, are one of the most common adverse events after TAVR. Among transcatheter heart valves (THV), rates of conduction abnormalities vary from less than 10 % to more than 50 %. Depending on the reported data referred to, historical data showed that up to one-third of the patients required implantation of a PPM following TAVR. Although generally considered as a minor complication, PPM may have a profound impact on prognosis and quality of life after TAVR. Current data support the hypothesis that conduction abnormalities leading to pacemaker dependency result from mechanical compression of the conduction system by the prosthesis stent frame and individual predisposing conduction defects such as right bundle-branch block (RBBB). With several large randomised trials and registry studies having been published recently and second generation THV having been introduced, the debate about predictors for pacemaker implantation and their impact on outcome after TAVR is still ongoing.
Marcel Weber - University of Bonn, Department of Internal Medicine II, Cardiology, Pulmonology and Angiology, Germany
Jan-Malte Sinning - University of Bonn, Department of Internal Medicine II, Cardiology, Pulmonology and Angiology, Germany
Christoph Hammerstingl - University of Bonn, Department of Internal Medicine II, Cardiology, Pulmonology and Angiology, Germany
Nikos Werner - University of Bonn, Department of Internal Medicine II, Cardiology, Pulmonology and Angiology, Germany
Eberhard Grube - Chief of the Department of Cardiology and Angiology, Siegburg Heart Centre, Germany
Georg Nickenig - University of Bonn, Department of Internal Medicine II, Cardiology, Pulmonology and Angiology, Germany
